Nexeon Medsystems (PRIVATE.NXMD)

Overall impact
B (67)

Commentary

Nexeon Medsystems is a strong overall performer. With a 'B' rating of 67.4 for overall impact (77th percentile compared to all companies), Nexeon Medsystems ranks 72nd out of 155 industry peers, behind American Shared Hospital Services, Accuray, BioSig Technologies and 68 others, and ahead of Hologic, Avinger, Adm Tronics Unlimited and 80 others. On top material causes for Nexeon Medsystems's industry (Healthcare Equipment), Nexeon Medsystems performs well in Improved Mental Health (95.2 score), Conflict Free Mineral Production (92.6) and Access to Affordable Healthcare (83.7) and performs poorly in Sanitation Access (32.1 score) and Disease Eradication (39.6).
Impact
Cause PRIVATE.NXMD
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2004
Employees
62
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Equipment
SASB industry
Medical Equipment & Supplies
Headquarters
Texas, United States
Share classes
PRIVATE.NXMD
NXMD
Description
Nexeon MedSystems Inc is a neuromodulation medical device manufacturing company. It is engaged in the development and commercialization of its neurostimulation technology platform for the treatment of disorders related to tissues of the nervous system.
Material causes
Ethos considers the following causes material for Nexeon Medsystems, based on its industry sub-industry Health Care Equipment. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.